Ethyl acetimidate hydrochloride, 97%
Ethyl acetimidate hydrochloride, 97%
Thermo Scientific Chemicals

Ethyl acetimidate hydrochloride, 97%

CAS: 2208-07-3 | C4H10ClNO | 123.58 g/mol
Have Questions?
變更視圖buttonViewtableView
Quantity:
10 g
50 g
250 g
產品號碼 A18618.30
亦稱為 A18618-30
價格 (TWD)
-
申請報價
Quantity:
250 g
Request bulk or custom format
化學識別
CAS2208-07-3
IUPAC Namehydrogen ethyl ethanimidate chloride
Molecular FormulaC4H10ClNO
InChI KeyWGMHMVLZFAJNOT-UHFFFAOYSA-N
SMILES[H+].[Cl-].CCOC(C)=N
檢視更多
規格Specification Sheet規格表
Appearance (Color)White
FormCrystals or powder or crystalline powder
Assay (Titration ex Chloride)≥96.0 to ≤104.0%
Ethyl acetimidate hydrochloride was used in preparation of amidinated carbonic anhydrase via chemical modification of human erythrocyte carbonic anhydrase. It was also used in synthesis of methyl 2-methyl-2-thiazoline-4-carboxylate hydrochloride.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
Ethyl acetimidate hydrochloride was used in preparation of amidinated carbonic anhydrase via chemical modification of human erythrocyte carbonic anhydrase. It was also used in synthesis of methyl 2-methyl-2-thiazoline-4-carboxylate hydrochloride.

Solubility
Soluble in water (50mg/L).

Notes
Moisture Sensitive, store away from water/moisture. Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Store under dry inert gas.
RUO – Research Use Only

General References:

  1. P L Whitney; P O Nyman; B G Malmström. Inhibition and chemical modifications of human erythrocyte carbonic anhydrase B. Journal of Biological Chemistry. 1967, 242 (18), 4212-4220.
  2. Smith HA: Goring G. 2-Methyl-2-thiazoline-4-carboxylic acid: formation from N-acetylcysteine and hydrolysis. J. Org. Chem. 1961, 26 (3), 820-23.